Last Price | 341.60 | Max Price | 455.75 |
Min Price | 328.90 | 1 Year return | 2.40 |
Avg. Target | 428.62 | Expected Return | 25.47 % |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Sell | 2 | Rating | |
Hold | 4 | Concensus | |
Buy | 7 | ||
Annual report 2012 |
L’Oréal is a French producer of cosmetic products. L’Oréal was founded in 1907. L’Oréal produces hair colouring, make-up and skin products, perfumes and other related products. Well known L’Oréal brands include Lancôme, Garnier and Cacharel. L’Oréal’s stocks are traded on the Euronext Paris and the company is a component of the CAC40-index (ISIN: FR0000120321/ Mnemo: OR).
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 29,874 | 2,019,579 | 1.48 % |
2020 | 27,992 | 2,170,517 | 1.29 % |
2021 | 32,288 | 2,404,876 | 1.34 % |
2022 | 38,261 | 2,645,792 | 1.45 % |
2023 | 0 | 0 | 0.00 % |
Analysts: L'Oreal on steam for record sales
Analysts expect over 2020 decreasing revenue L'Oreal
Analysts expect over 2020 rising revenue L'Oreal
Analysts think LOreal is fairly priced
L’Oreal confident it can survive amid Wall Street’s downfall
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
L'Oreal mainly operates in the health care eq. & services sector. The global health care companies gained around 102 percent over the period 2006-2016. Since 2011 the sector is 64 percent higher and over the past year plus 102 percent.
The period between December 2015 and December 2016 was a profitable period for the investors in L'Oreal. The stock gained around 10 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 114 percent. L'Oreal's revenues between 2011 and 2015 were quite stable and moved between 22,46 billion euros and 25,26 billion euros. During 2011 and 2015 L'Oreal's net results were very volatile and fluctuated between 2,44 billion euros and 3,29 billion euros.
The French company paid out dividends in the past 5 years. On average the L'Oreal stock yielded a delivered a dividend yield of around 12,6 percent over the past 5 years. In the period 2011 till 2015 L'Oreal paid it's investors each year a higher dividend per share. Based on the raising dividend payments L'Oreal can be seen as a kind of dividend aristocrat.
At the end of 2015 L'Oreal employed at around 78,61 thousand people.
At the end of 2015 the French company had a balance sheet of 33,71 billion euros. Last year the total debt of the company was 10,1 billion euros. This equals around 29,95 percent of the total balance sheet. As per the end of 2015 L'Oreal's price/earnings-ratio equaled 23. So investors paid for 1 stock 23 times the earnings per share of 2015. We could say that based on it's price/earnings-ratio and dividend yield the French stock can be seen as a value stock.
The health care company's market capitalization (the number of shares outstanding times the market value) equaled around 84,1 billion euros. At the end of 2015 the French company had around 557,35 million stocks listed on the exchanges.
At this page you find all L'Oreal's financial reports. More information about L'Oreal can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
25,257
|
25,837
|
26,024
|
26,937
|
29,874
|
27,992
|
Costs |
21,960
|
22,731
|
22,442
|
23,042
|
26,124
|
24,429
|
Profit |
3,297
|
3,106
|
3,581
|
3,895
|
3,750
|
3,563
|
Margin of profit |
13.06
|
12.02
|
13.76
|
14.46
|
12.55
|
12.73
|
ROI |
13.96
|
12.68
|
14.43
|
14.47
|
12.75
|
12.29
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
23,614
|
24,502
|
24,816
|
26,928
|
29,419
|
28,993
|
Debt |
10,097
|
11,128
|
10,523
|
11,529
|
14,391
|
14,614
|
Total assets |
33,711
|
35,630
|
35,339
|
38,458
|
43,810
|
43,607
|
Solvency |
70.05
|
68.77
|
70.22
|
70.02
|
67.15
|
66.49
|
Cash |
1,502
|
1,796
|
3,070
|
4,015
|
5,309
|
6,413
|
Cashflow |
4,203
|
4,705
|
5,159
|
5,292
|
6,263
|
6,453
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.42
|
0.42
|
0.49
|
0.46
|
0.44
|
0.44
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
155.30
|
173.40
|
184.95
|
201.20
|
264.00
|
Eps |
5.50
|
6.36
|
6.92
|
6.66
|
6.34
|
Price/earnings-ratio |
28.24
|
27.26
|
26.73
|
30.21
|
53.88
|
Dividend |
3.30
|
3.55
|
3.85
|
3.85
|
4.00
|
Dividend % |
2.12 %
|
2.05 %
|
2.08 %
|
1.91 %
|
1.17 %
|
Payout % |
0.60
|
0.56
|
0.56
|
0.58
|
0.63
|
Book value |
43.75
|
44.33
|
48.12
|
52.71
|
51.79
|
Market to book |
0.28
|
0.26
|
0.26
|
0.26
|
0.15
|
Cashflow per stock |
8.40
|
9.22
|
9.46
|
11.22
|
11.53
|
Stocks |
560
|
560
|
560
|
558
|
560
|
Market Cap |
86.983.28
|
97.060.30
|
103.502.83
|
112.293.14
|
191.252.28
|
Date
|
Price
|
---|---|
17 Dec 2024
|
341.60
|
10 Dec 2024
|
349.70
|
06 Dec 2024
|
336.15
|
03 Dec 2024
|
333.50
|
29 Nov 2024
|
328.90
|
27 Nov 2024
|
332.45
|
13 Nov 2024
|
329.00
|
08 Nov 2024
|
345.95
|
05 Nov 2024
|
344.40
|
31 Oct 2024
|
348.70
|
29 Oct 2024
|
359.55
|
23 Oct 2024
|
367.25
|
19 Oct 2024
|
372.70
|
16 Oct 2024
|
368.20
|
14 Oct 2024
|
391.55
|
05 Oct 2024
|
393.35
|
02 Oct 2024
|
391.60
|
27 Sep 2024
|
408.65
|
20 Sep 2024
|
379.00
|
17 Sep 2024
|
365.90
|
13 Sep 2024
|
365.20
|
28 Aug 2024
|
392.25
|
26 Aug 2024
|
395.30
|
23 Aug 2024
|
392.25
|
11 Aug 2024
|
382.75
|
07 Aug 2024
|
391.00
|
05 Aug 2024
|
384.95
|
01 Aug 2024
|
400.65
|
30 Jul 2024
|
392.60
|
26 Jul 2024
|
392.35
|